epigallocatechin gallate has been researched along with Periapical Periodontitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo Ferreira, DC; da Silva, LAB; da Silva, RS; De Rossi, A; Liévana, FS; Moraes, JCB; Nelson-Filho, P; Vilela, MM | 1 |
| Chen, MH; Hong, CY; Hou, KL; Kok, SH; Lee, YL; Lin, SK; Lin, YT; Wang, CC | 1 |
2 other study(ies) available for epigallocatechin gallate and Periapical Periodontitis
| Article | Year |
|---|---|
An Epigallocatechin-3-gallate Formulation Developed for Endodontic Use: A Physicochemical and Biological Evaluation.
Topics: Animals; Calcium Hydroxide; Catechin; Dogs; Mice; Periapical Periodontitis; Periapical Tissue | 2021 |
An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Catechin; Cell Line, Tumor; Chemokine CCL2; Chemotaxis, Leukocyte; Cysteine-Rich Protein 61; Disease Models, Animal; Humans; Oncostatin M; Osteoblasts; Periapical Periodontitis; Plant Extracts; Rats; Rats, Wistar; Tea | 2009 |